The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
Open accessAbstract
Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. These barriers can affect drug entry into the eye following multiple routes of administration (e.g., topical, systemic, and injectable). Topical administration in the form of eye drops is preferred for treating anterior segment diseases, as it is convenient and provides local delivery of drugs. Major concerns with topical delivery include poor drug absorption and low bioavailability. To improve the bioavailability of topically administered drugs, novel drug delivery systems are being investigated. Nanocarrier delivery systems demonstrate enhanced drug permeation and prolonged drug release. This review provides an overview of ocular barriers to anterior segment delivery, along with ways to overcome these barriers using nanocarrier systems. The disposition of nanocarriers following topical administration, their safety, toxicity and clinical trials involving nanocarrier systems are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Global estimates of visual impairment: 2010
Pascolini, D., & Mariotti, S. P. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300539 · Cited by 3,763
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Occludin: a novel integral membrane protein localizing at tight junctions.
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1777 · Cited by 2,580
Surfactants and Interfacial Phenomena
Rosen, M. J., & Kunjappu, J. T. (2012) · Wiley eBooks · doi:10.1002/9781118228920 · Cited by 2,535
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Block copolymer micelles as long-circulating drug vehicles
Kwon, G. S., & Kataoka, K. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00031-2 · Cited by 823
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Self-citationA PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Structure, biochemistry, and assembly of epithelial tight junctions
Gumbiner, B. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c749 · Cited by 531
Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1.
Gumbiner, B., Lowenkopf, T., & Apatira, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3460 · Cited by 523
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
LEE, V. H. L., & ROBINSON, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 503
Harada, A., & Kataoka, K. (1998) · Macromolecules · doi:10.1021/ma971277v · Cited by 482
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Micellar solubilization of drugs.
Rangel‐Yagui, C. D. O., Pessoa, A., & Tavares, L. C. (2005) · PubMed · Cited by 447
The structure of micelles and microemulsions
Chevalier, Y., & Zemb, T. (1990) · Reports on Progress in Physics · doi:10.1088/0034-4885/53/3/002 · Cited by 431
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.10 · Cited by 358 · cited 3×
“Normal micelles are employed to encapsulate, solubilize, and delive hydr phobic drugs, whereas rev rse nanomicelles are utilized to encaps late and deliver hydrophilic drugs [91].”
BackgroundOcular absorption following topical delivery
Järvinen, K., Järvinen, T., & Urtti, A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00010-5 · Cited by 358
Ocular drug delivery conventional ocular formulations
Lang, J. C. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00012-v · Cited by 356
Lacrimal and Instilled Fluid Dynamics in Rabbit Eyes
Chrai, S. S., Patton, T. F., Mehta, A., & Robinson, J. R. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600620712 · Cited by 354
Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen
Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Microemulsions as ocular drug delivery systems: recent developments and future challenges
Vandamme, T. F. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00017-9 · Cited by 345
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 341
Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)
Helgason, T., Awad, T. S., Kristbergsson, K., McClements, D. J., & Weiss, J. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.03.012 · Cited by 340
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
Abdelbary, G., & El-gendy, N. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9105-1 · Cited by 333
Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
Ihre, H. R., Padilla De Jesús, O. L., Szoka, & Fréchet, J. M. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010102u · Cited by 332
P-Glycoproteins and Multidrug Resistance
Bellamy, W. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001113 · Cited by 319
Ocular Preparations: The Formulation Approach
Pal Kaur, I., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
de la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1077 · Cited by 287
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
A study of the causes of non-compliance by patients prescribed eyedrops.
Winfield, A. J., Jessiman, D., Williams, A., & Esakowitz, L. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.8.477 · Cited by 281
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Minimizing systemic absorption of topically administered ophthalmic drugs
Urtti, A., & Salminen, L. (1993) · Survey of Ophthalmology · doi:10.1016/0039-6257(93)90141-s · Cited by 265
Jung, H. J., Abou-Jaoude, M., Carbia, B. E., Plummer, C., & Chauhan, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.010 · Cited by 256
Solid lipid nanoparticles for ocular drug delivery
Seyfoddin, A., Shaw, J., & Al-Kassas, R. (2010) · Drug Delivery · doi:10.3109/10717544.2010.483257 · Cited by 247
Sammalkorpi, M., Karttunen, M., & Haataja, M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp901228v · Cited by 236
De Campos, A. M., Sánchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00178-7 · Cited by 234
Mechanistic and Quantitative Evaluation of Precorneal Pilocarpine Disposition in Albino Rabbits
Lee, V. H.-L., & Robinson, J. R. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680606 · Cited by 230
Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Polyamidoamine Starburst® dendrimers as solubility enhancers
Milhem, O. M., Myles, C., McKeown, N. B., Attwood, D., & D’Emanuele, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00463-9 · Cited by 227
Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses
Kim, J., Conway, A., & Chauhan, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.030 · Cited by 223
Aggarwal, D., & Kaur, I. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.026 · Cited by 223
Rojanasakul, Y., Wang, L.-Y., Bhat, M., Glover, D. D., Malanga, C. J., & Ma, J. K. H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015802427428 · Cited by 213
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
Calvo, P., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb03911.x · Cited by 206
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.007 · Cited by 200
Maulvi, F. A., Lakdawala, D. H., Shaikh, A. A., Desai, A. R., Choksi, H. H., Vaidya, R. J., Ranch, K. M., Koli, A. R., Vyas, B. A., & Shah, D. O. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.012 · Cited by 200
Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 196
Nanocarriers in Ocular Drug Delivery: An Update Review
Wadhwa, S., Paliwal, R., Paliwal, S., & Vyas, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788923886 · Cited by 196
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery
Cholkar, K., Patel, A., Dutt Vadlapudi, A., & K. Mitra, A. (2012) · Recent Patents on Nanomedicinee · doi:10.2174/1877912311202020082 · Cited by 193
New vehicle based on a microemulsion for topical ocular administration of dexamethasone
Fialho, S. L., & Da Silva‐Cunha, A. (2004) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2004.00914.x · Cited by 193
Novel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189
Nanomaterials for Ocular Drug Delivery
Liu, S., Jones, L., & Gu, F. X. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100419 · Cited by 185
Transport processes across the rabbit corneal epithelium: a review
Klyce, S. D., & Crosson, C. E. (1985) · Current Eye Research · doi:10.3109/02713688509025145 · Cited by 185
Ocular Drug Delivery: Pharmacokinetic Considerations
Schoenwald, R. D. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018040-00001 · Cited by 183
Ooya, T. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.07.001 · Cited by 179
Kawashima, Y., Niwa, T., Handa, T., 洋文, 竹., Iwamoto, T., & Itoh, K. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780118 · Cited by 178
Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy
Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. (2015) · ACS Nano · doi:10.1021/nn506599f · Cited by 177
Zhang, G.-D., Harada, A., Nishiyama, N., Jiang, D.-L., Koyama, H., Aida, T., & Kataoka, K. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.05.002 · Cited by 174
Abdelkader, H., Ismail, S., Kamal, A., & Alany, R. G. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22422 · Cited by 169
Losa, C., Marchal-Heussler, L., Orallo, F., Jato, J. L. V., & Alonso, M. J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018977130559 · Cited by 163
Controlled ocular drug delivery with nanomicelles
Vaishya, R. D., Khurana, V., Patel, S., & Mitra, A. K. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1272 · Cited by 162
Gupta, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00508-1 · Cited by 160
Dispersion of DMPC Liposomes in Contact Lenses for Ophthalmic Drug Delivery
Gulsen, D., Li, C.-C., & Chauhan, A. (2005) · Current Eye Research · doi:10.1080/02713680500346633 · Cited by 159
Sustained in vivo release from imprinted therapeutic contact lenses
Tieppo, A., White, C. J., Paine, A. C., Voyles, M. L., McBride, M. K., & Byrne, M. E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.087 · Cited by 158
Recent Advances and Patents on Solid Lipid Nanoparticles
Sawant, K. K., & Dodiya, S. S. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534081 · Cited by 158
Sears, M. L. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69222-2 · Cited by 157
Zhang, T., Xiang, C. D., Gale, D. C., Carreiro, S. T., Wu, E. Y., & Zhang, E. Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021121 · Cited by 156
Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs
Kapoor, Y., Thomas, J. C., Tan, G., John, V. T., & Chauhan, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.032 · Cited by 151
Duan, Y., Cai, X., Du, H., & Zhai, G. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.007 · Cited by 150
Kawashima, Handa, Takéuchi, & Iwamoto (1990) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 150
Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration
Vega, E., Egea, M. A., Valls, O., Espina, M., & García, M. L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20685 · Cited by 137
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
Venkatraman, S. S., Natarajan, Ang, M., Darwitan, & Wong (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25468 · Cited by 136
Sustained Drug Release in Nanomedicine: A Long-Acting Nanocarrier-Based Formulation for Glaucoma
Natarajan, J. V., Darwitan, A., Barathi, V. A., Ang, M., Htoon, H. M., Boey, F., Tam, K. C., Wong, T. T. L., & Venkatraman, S. S. (2014) · ACS Nano · doi:10.1021/nn4046024 · Cited by 135
Gan, L., Gan, Y., Zhu, C., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.004 · Cited by 133
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
Liaw, J., Chang, S.-F., & Hsiao, F.-C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301485 · Cited by 127
Development of Effective Ocular Preparations of Antifungal Agents
Kaur, I. P., Rana, C., & Singh, H. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0031 · Cited by 124
Ibrahim, H. K., El-Leithy, I. S., & Makky, A. A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900279c · Cited by 124
Nasr, F. H., Khoee, S., Dehghan, M. M., Chaleshtori, S. S., & Shafiee, A. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01387 · Cited by 121
Hao, J., Wang, X., Bi, Y., Teng, Y., Wang, J., Li, F., Li, Q., Zhang, J., Fengguang, G., & Liu, J. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.09.059 · Cited by 120
Dendrimeric Systems and Their Applications in Ocular Drug Delivery
Yavuz, B., Pehlivan, S. B., & Ünlü, N. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/732340 · Cited by 120
Sharma, A., Tandon, A., Tovey, J. C. K., Gupta, R., Robertson, J. D., Fortune, J. A., Klibanov, A. M., Cowden, J. W., Rieger, F. G., & Mohan, R. R. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.006 · Cited by 117
Dietlein, T. S., Jordan, J. F., Lüke, C., Schild, A. M., Dinslage, S., & Krieglstein, G. K. (2008) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2007.01155.x · Cited by 115
Transport mechanisms of the cornea: characterization of barrier permselectivity
Rojanasakul, Y., & Robinson, J. R. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90047-1 · Cited by 114
Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate
Yu, S., Wang, Q., Wang, X., Liu, D., Zhang, W., Ye, T., Yang, X., & Pan, W. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.032 · Cited by 113
Abrego, G., Alvarado, H. L., Souto, E. B., Guevara, B., Halbaut, L., Parra, A., Calpena, A. C., & García, M. L. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.026 · Cited by 112
Gaafar, P. M. E., Abdallah, O. Y., Farid, R. M., & Abdelkader, H. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.881850 · Cited by 108
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Shen, Y., & Tu, J. (2007) · The AAPS Journal · doi:10.1208/aapsj0903044 · Cited by 106
Dexamethasone nanowafer as an effective therapy for dry eye disease
Coursey, T. G., Henriksson, J. T., Marcano, D. C., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.007 · Cited by 105
Contreras‐Ruiz, L., de la Fuente, M., Párraga, J. E., López‐García, A., Fernández, I., Seijo, B., Sánchez, A., Calonge, M., & Diebold, Y. (2011) · PubMed Central · Cited by 105
Almeida, H., Amaral, M. H., Lobão, P., Silva, A. C., & Lobo, J. M. S. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3dp43 · Cited by 105
Studies on the transport pathway of PBCA nanoparticles in ocular tissues
Zimmer, A., Kreuter, J., & Robinson, J. R. (1991) · Journal of Microencapsulation · doi:10.3109/02652049109021873 · Cited by 102
Losa, C., Calvo, P., Castro, E., Vila-Jato, J. L., & Alonso, M. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03534.x · Cited by 102
Shi, S., Zhang, Z., Luo, Z., Yu, J., Liang, R., Li, X., & Chen, H. (2015) · Scientific Reports · doi:10.1038/srep11337 · Cited by 101
Natarajan, J. V., Chattopadhyay, S., Ang, M., Darwitan, A., Foo, S. E. M., Zhen, M., Koo, M., Wong, T. T. L., & Venkatraman, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024513 · Cited by 100
Microemulsion: New Insights into the Ocular Drug Delivery
Hegde, R. R., Verma, A. K., & Ghosh, A. (2013) · ISRN Pharmaceutics · doi:10.1155/2013/826798 · Cited by 97
The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers
Holash, J. A., & Stewart, P. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91323-k · Cited by 95
A Nonionic Surfactant/Chitosan Micelle System in an Innovative Eye Drop Formulation
Pepić, I., Hafner, A., Lovrić, J., Pirkić, B., & Filipović‐Grčić, J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22137 · Cited by 94
Danion, A., Arsenault, I., & Vermette, P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20871 · Cited by 93
ElShaer, A., Mustafa, S. M., Kasar, M., Thapa, S., Ghatora, B., & Alany, R. G. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020014 · Cited by 92
Calvo, P., THOMAS, C., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90179-1 · Cited by 91
Bu, H., Gukasyan, H. J., Goulet, L., Lou, X., Xiang, C. D., & Koudriakova, T. B. (2007) · Current Drug Metabolism · doi:10.2174/138920007779815977 · Cited by 91
Micellar solutions of triblock copolymer surfactants with pilocarpine
Pepić, I., Jalšenjak, N., & Jalšenjak, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.032 · Cited by 84
Di Tommaso, C., Torriglia, A., Furrer, P., Behar-Cohen, F., Gurny, R., & Möller, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.004 · Cited by 84
Gokce, E. H., Sandri, G., Eğrilmez, S., Bonferoni, M. C., Güneri, T., & Caramella, C. M. (2009) · Current Eye Research · doi:10.3109/02713680903261405 · Cited by 84
Maulvi, F. A., Choksi, H. H., Desai, A. R., Patel, A. S., Ranch, K. M., Vyas, B., & Shah, D. O. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.05.064 · Cited by 83
Aukunuru, J., Sunkara, G., Bandi, N., Thoreson, W. B., & Kompella, U. B. (2001) · Pharmaceutical Research · doi:10.1023/a:1011060705599 · Cited by 82
Safety and toxicity of nanomaterials for ocular drug delivery applications
Mehra, N. K., Cai, D., Kuo, L., Hein, T. W., & Palakurthi, S. (2016) · Nanotoxicology · doi:10.3109/17435390.2016.1153165 · Cited by 80
Charged nanoparticles delivery to the eye using hydrogel iontophoresis
Eljarrat‐Binstock, E., Orucov, F., Aldouby, Y., Frucht‐Pery, J., & Domb, A. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.016 · Cited by 78
Kesavan, K., Kant, S., Singh, P. N., et al. (2012) · Current Eye Research · doi:10.3109/02713683.2012.745879 · Cited by 77
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Improved and Safe Transcorneal Delivery of Flurbiprofen by NLC and NLC-Based Hydrogels
González‐Mira, E., Nikolić, S., Calpena, A. C., Egea, M. A., Souto, E. B., & García, M. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22784 · Cited by 76
Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas, S. P., Mysore, N., Jaitely, V., & Venkatesan, N. (1998) · PubMed · Cited by 76
Eye drop delivery of nano‐polymeric micelle formulated genes with cornea‐specific promoters
Tong, Y.-C., Chang, S., Liu, C., Kao, W. W. ‐., Huang, C. H., & Liaw, J. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1093 · Cited by 71
The effect of drug charge type and charge density on corneal transport
Liaw, J., Rojanasakul, Y., & Robinson, J. R. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90308-o · Cited by 70
Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells.
Saha, P., Yang, J. J., & Lee, V. H. L. (1998) · PubMed · Cited by 69
P-Glycoprotein expression in human retinal pigment epithelium cell lines
Constable, P. A., Lawrenson, J. G., Dolman, D. E. M., Arden, G. B., & Abbott, N. J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.029 · Cited by 68
Design of liposomal colloidal systems for ocular delivery of ciprofloxacin
Taha, E. I., El-Anazi, M. H., Elbagory, I., & Bayomi, M. A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.07.003 · Cited by 68
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement
Shen, J., Sun, M., Ping, Q. N., Zhi, Y., & Liu, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/21/2/025101 · Cited by 68
Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits
Kuwano, M., Ibuki, H., Morikawa, N., Ota, A., & Kawashima, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1013671819604 · Cited by 67
Bhat, M., Toledo‐Velasquez, D., Wang, L., Malanga, C. J., Ma, J. K. H., & Rojanasakul, Y. (1993) · Pharmaceutical Research · doi:10.1023/a:1018906504944 · Cited by 64
Vadlapudi, A. D., Cholkar, K., Vadlapatla, R. K., & Mitra, A. K. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0157 · Cited by 62
Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea
Muchtar, S., Abdulrazik, M., Frucht‐Pery, J., & Benita, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01503-9 · Cited by 62
Novel pluronic‐chitosan micelle as an ocular delivery system
Lin, H., & Chang, P. (2013) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32871 · Cited by 59
Das, N. D., & Shichi, H. (1981) · Experimental Eye Research · doi:10.1016/s0014-4835(81)80127-3 · Cited by 57
Expression of Efflux Transporters in Human Ocular Tissues
Chen, P., Chen, H., Zang, X., Chen, M., Jiang, H., Han, S., & Wu, X. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052704 · Cited by 56
Meseguer, G., Gurny, R., & Buri, P. A. (1994) · Journal of drug targeting · doi:10.3109/10611869409015908 · Cited by 55
Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide
Sun, Y., Fox, T. E., Adhikary, G., KESTER, M. A., & Pearlman, E. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108076 · Cited by 55
Bharti, S. K., & Kesavan, K. (2016) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2016.1139136 · Cited by 49
Boddu, S. H. S., Gunda, S., Earla, R., & Mitra, A. K. (2010) · Bioanalysis · doi:10.4155/bio.10.2 · Cited by 46
Self-citationAbdelrahman, A. A., Salem, H. F., Khallaf, R. A., & Ali, A. M. A. (2015) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-015-9224-7 · Cited by 45
Marcano, D. C., Shin, C. S., Lee, B., Isenhart, L. C., Liu, X., Li, F., Jester, J. V., Pflugfelder, S. C., Simpson, J. L., & Acharya, G. S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00488 · Cited by 44
Conjunctival penetration of insulin and peptide drugs in the albino rabbit.
Hayakawa, E., Chien, D., Inagaki, K., et al. (1992) · Pharmaceutical Research · doi:10.1023/a:1015803605621 · Cited by 41
Ocular Sustained Release Nanoparticles Containing Stereoisomeric Dipeptide Prodrugs of Acyclovir
Jwala, J., Boddu, S. H. S., Shah, S. J., Sirimulla, S., Pal, D., & Mitra, A. K. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0188 · Cited by 40
Self-citationKuo, T., Lee, C.-F., Lin, S., Dong, C., Chen, C., & Tan, H. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100376n · Cited by 40
Roelofsen, H., Hooiveld, G. J. E. J., Koning, H., Havinga, R., Jansen, P. L. M., & Müller, M. M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.9.1395 · Cited by 40
de Castro, E. D. M., Taboada, P., & Mosquera, V. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp044766n · Cited by 38
De, T., Bergey, E. J., Chung, S. J., Rodman, D. J., Bharali, D. J., & Prasad, P. N. (2004) · Journal of Microencapsulation · doi:10.1080/02652040400008515 · Cited by 37
Tong, Y.-C., Chang, S., Kao, W. W. ‐., Liu, C., & Liaw, J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.006 · Cited by 35
Suresh, P. K., & Sah, A. K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938045 · Cited by 34
Nanotechnology for the Prevention and Treatment of Cataract
Çetinel, S., & Montemagno, C. D. (2015) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000156 · Cited by 28
Polymeric Nanoparticles for Ophthalmic Drug Delivery: An Update on Research and Patenting Activity
Boddu, S. H. S. (2012) · Current Nanomedicine · doi:10.2174/1877912311202020096 · Cited by 27
Self-citationYang, J. J., Ann, D. K., Kannan, R., & Lee, V. H. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9267-7 · Cited by 26
Kim, J., Schlesinger, E. B., & Desai, T. A. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.75 · Cited by 17
Polymeric Micelles for Ocular Delivery: Progress and Issues
Akhtar, N., & Pathak, K. (2015) · Pharmaceutical Nanotechnology · doi:10.2174/2211738504666151127192330 · Cited by 2
Cited by
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Hydrogel-based commercial products for biomedical applications: A review
Cascone, S., & Lamberti, G. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118803 · Cited by 421
Ocular Drug Delivery: a Comprehensive Review
Ahmed, S., Amin, M. M., & Sayed, S. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02516-9 · Cited by 352
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Nanocarriers for ocular drug delivery: current status and translational opportunity
Gorantla, S., Rapalli, V. K., Waghule, T., Singh, P. P., Dubey, S. K., Saha, R. N., & Singhvi, G. (2020) · RSC Advances · doi:10.1039/d0ra04971a · Cited by 313
Metadata
- Authors
- Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-02-27
- Volume
- 10
- Issue
- 1
- Pages
- 28
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2792337208
- Cited by
- 421
- References
- 165
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.